Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,062 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension

NCT00851929

Conditions: Cardiovascular Diseases, Dyspnea, Hemic and Lymphatic Diseases, +16 more
Locations: University of North Carolina Medical Center Chapel Hill, North Carolina, United States

Medical Univerrsity of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

NCT02206503

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Policlinico Umberto I Rome, Italy

View Trial Details

Completed

Effect of Bovine Colostrum on Toxicity and Inflammatory Responses

NCT01766804

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Rigshospitalet Copenhagen, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Completed

Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

NCT00484874

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
Locations: Johns Hopkins Medical Institutions Baltimore, Maryland, United States

View Trial Details

Completed

Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

NCT01482962

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Birmingham, Alabama, United States

La Jolla, California, United States

Orlando, Florida, United States

Tampa, Florida, United States

View all 151 locations

View Trial Details

Completed

Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma

NCT02331368

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

NCT01789255

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +176 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis

NCT01777243

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
Locations: GSK Investigational Site Cambridge, United Kingdom

GSK Investigational Site London, United Kingdom

View Trial Details

Completed

A Study of PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/Lymphoma

NCT01973387

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Concord, Australia

Gosford, Australia

Heidelberg, Australia

Perth, Australia

View all 26 locations

View Trial Details

Completed

Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma

NCT00026208

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
Locations: Stanford University School of Medicine Stanford, California, United States

Kaiser Permanente Medical Center Vallejo, California, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions